Welcome to the Wisdom Series
Message from the Wisdom Series Editor: The Wisdom series is targeted at junior and mid-career FIDSSA members. The aims of this series are two-fold: first, to outline the diversity of careers in infectious diseases in South Africa and second, to provide a permanent library of mentor and mentee resources for our members.
Using a mix of written contributions and pre-recorded interviews, we invited respected people in the local infectious diseases community to reflect on their personal career trajectories, the impact of their work, the mistakes they had made along the way and the advice they would give to FIDSSA members for happy and fulfilling careers. FIDSSA members nominated people working in three main tracks – academic, clinical and public health – and we aimed to include a good mix of contributors, in the middle of their careers as well as experienced wise voices, reflecting our broader membership.
We hope that you enjoy these resources and find them helpful in your own career.
Best wishes, Nelesh Govender (FIDSSA President, 2017-2021)
Click on the video to listen to a recorded introduction by Professor Nelesh Govender
Upcoming Interview Premieres
Dr Kirti Ranchod from Memorability has pre-recorded interviews with five of our contributors. These interviews will be premiered over the next 5 weeks, starting on 1 June 2022.
Premiere on 1 June 2022 at 17h00
Click on the
YouTube video to listen to a short excerpt of the interview with Professor Shabir
Madhi. The full interview will be available to FIDSSA members only on the premiere
Professor Shabir Madhi
Professor Madhi is the Dean of the Faculty of Health Sciences and Professor of Vaccinology at the University of the Witwatersrand, Johannesburg; and the Co-Founder/ Co-Director of the African Leadership Initiative for Vaccinology Expertise (ALIVE).
ORCID profile: https://orcid.org/0000-0002-7629-0636
Premiere on 8 June 2022 at 17h00
Click on the YouTube video to listen to a short excerpt of the interview with Professor Lucille Blumberg. The full interview will be available to FIDSSA members on the premiere date.
Professor Lucille Blumberg
Professor Blumberg is an Honorary Consultant at the National Institute for Communicable Diseases, Johannesburg; Consultant at Right to Care, Johannesburg; Extraordinary Lecturer in Veterinary Tropical Diseases at the University of Pretoria and Vice-chair of the WHO Review Committee on the Functioning of the International Health Regulations during the COVID-19 Response.ORCID profile: https://orcid.org/0000-0002-2828-7678
Premiere on 22 June 2022 at 17h00
Click on the YouTube video to listen to a short excerpt of the interview with Professor Koleka Mlisana. The full interview will be available to FIDSSA members on the premiere date.
A/Professor Koleka Mlisana
A/Professor Mlisana is an Associate Professor and Head of Department: Medical Microbiology at the University of KwaZulu-Natal, Durban; and Executive Manager: Academic Affairs, Research & Quality Assurance, National Health Laboratory Service, Sandringham.ORCID profile: https://orcid.org/0000-0002-8436-3268
Premiere on 29 June 2022 at 17h00
Click on the YouTube video to listen to a short excerpt of the interview with Dr David Stead. The full interview will be available to FIDSSA members on the premiere date.
Dr David Stead
Dr Stead is an infectious diseases physician in the Division of
Infectious Diseases, Internal Medicine, Frere & Cecilia Makiwane hospitals,
East London; and is affiliated to the Department of Medicine, Faculty of Health
Sciences, Walter Sisulu University, Mthatha.
Premiere on 6 July 2022 at 17h00
Click on the YouTube video to listen to a short excerpt of the interview with Professor Shaheen Mehtar. The full interview will be available to FIDSSA members on the premiere date.
Professor Shaheen Mehtar
Link to SAJID article: Hope and challenges working at the frontiers of medical knowledge.
Prof Graeme Meintjes is an infectious diseases physician and the Second Chair and Deputy Head of the Department of Medicine at the University of Cape Town. He also holds the SARChI Chair of Poverty-related Infections.
Link to SAJID article: A terrific journey for which I have great gratitude.
Prof Linda-Gail Bekker is Professor of Medicine and Director of the Desmond Tutu HIV Centre at the University of Cape Town and the Chief Operating Officer of the Desmond Tutu HIV Foundation, Cape Town. She is a Past President of the International AIDS Society (2016-2018).
Link to SAJID articl article: Endless forms most beautiful.
Dr Jeremy Nel is Head of Infectious Diseases at Helen Joseph Hospital and is affiliated to the University of the Witwatersrand, Johannesburg.
Access all full videos and SAJID Wisdom supplement by logging in
Antimicrobial resistance (AMR) is a significant public health threat. The problem of AMR is growing, and yet few companies today are actively working on developing new antibiotics.
After a century of research and development in infectious diseases, our company knows there is no single or simple answer to the complex problem of antimicrobial resistance. As the currently available antibiotics become less effective because of AMR, millions of lives are threatened.
The need for new medicines that are effective against multi-drug resistant bacteria is significant and urgent.
At MSD, we are committed to playing our part in the global response to AMR — not only through investments in the development of new vaccines and treatments for unmet medical needs, but also in our work to support the appropriate use of these products around the world.
For over 80 years, our company has brought forward new treatments each decade in every area of infectious disease and in multiple modalities, including small molecules, vaccines and monoclonal antibodies.
MSD is determined to mobilize expertise and resources with the goal of staying one step ahead of some of the world’s greatest killers. Our company continues to push the boundaries of science with the hope and expectation of inventing for the single greatest purpose – life.
We all have a responsibility to address this threat, and it will take dedicated efforts from all sectors across health care, including patients, to make a difference. We must put measures in place to ensure that we have the antibiotics we need — today and in the future. The time to act is now.